Table 1 Baseline Characteristics
w/o markers n = 287 | w/ markers n = 182 | P | |
|---|---|---|---|
Age, y | 60.0 [52.0–69.0] | 56.0 [46.0–65.0] | < 0.01 |
Female | 40 (13.9%) | 30 (16.5%) | 0.45 |
BMI, kg/m2 | 27 [25–30] | 25.5 [23, 28] | 0.00 |
Arterial hypertension | 280 (97.6%) | 178 (97.8%) | 1.00 |
Diabetes mellitus | 7 (2.4%) | 4 (2.2%) | 0.87 |
Creatinine, mg/dl | 0.9 [0.8–1.1] | 0.9 [0.8–1.1] | 0.67 |
GFR, ml/min | 84.9 [68.3–95.4] | 86.5 [74.6–97.1] | 0.13 |
NYHA | 0.83 | ||
I II III IV | 280 (97.6%) 3 (1.0%) 2 (0.7%) 2 (0.7%) | 178 (97.8%) 3 (1.6%) 1 (0.5%) 0 (0.0%) | |
LVEF, % | 53 [45–60] | 56 [47–61] | 0.20 |
CAOD | 0.05 | ||
No CAOD 1 vessel 2 vessels 3 vessels | 214 (74.6%) 30 (10.5%) 28 (9.8%) 15 (5.2%) | 142 (77.0%) 19 (10.4%) 11 (6.0%) 10 (5.5%) | |
Previous cardiac surgery | 6 (2.1%) | 1 (0.5%) | 0.18 |
Emergency operation | 17 (5.9%) | 4 (2.2%) | 0.06 |
In-hospital stay, d | 15 [12–19] | 13 [11–16] | < 0.01 |
Intensive unit care stay, d | 0.98 [0.85–2.86] | 0.95 [0.88–1.99] | 0.97 |
30-days mortality | 28 (9.8%) | 3 (1.6%) | < 0.01 |